Abstract Coronavirus disease 2019 (COVID‐19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to an unprecedented setback for …

Background: To date, coronavirus disease 2019 (COVID-19) becomes increasingly fierce
due to the emergence of variants. Rapid herd immunity through vaccination is needed to …

Objectives To describe the safety of vaccines against SARS-CoV-2 in people with
inflammatory/autoimmune rheumatic and musculoskeletal disease (I-RMD). Methods …

As the coronavirus disease 2019 (COVID-19) pandemic continues worldwide, vaccination
has been considered an effective measure to protect people from the COVID-19 and end the …

Data regarding COVID-19 vaccine efficacy and adverse events (AE) in patients with
autoimmune and inflammatory rheumatic diseases (AIIRD) have been published recently …

Immune thrombocytopenia (ITP) is an acquired autoimmune disorder that is characterized
by low platelet count and increased bleeding risk. COVID-19 vaccination has been …

Patients with systemic lupus erythematosus (SLE) form a vulnerable group in terms of the
impact of the COVID-19 pandemic on disease management. We conducted this overview by …

The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has captivated the globe's attention since its emergence in 2019. This highly …

Background: Reports describing post-vaccine autoimmune phenomena, in previously
healthy individuals, increased the concerns regarding the risk of disease flare-ups in …

Background Vaccine-induced immunity is essential for controlling the COVID-19 pandemic.
Data on humoral and cellular immunogenicity and safety of different SARS-CoV-2 vaccines …